UNIGE IRISmetadata only
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‐dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
auto, research
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 202764
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.